Aimei Health Technology Co., Ltd (AFJK)
$
11.2
+0.06 (0.54%)
Key metrics
Financial statements
Free cash flow per share
-0.0745
Market cap
67.5 Million
Price to sales ratio
0
Debt to equity
0.0031
Current ratio
0.0372
Income quality
-0.2634
Average inventory
0
ROE
0.0479
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The EBITDA is -$1,064,786.00 a key indicator of the company's operational profitability, which provides insight into its ability to generate earnings before interest, taxes, depreciation, and amortization. In assessing profitability, the company recorded a net income of $2,552,215.00 reflecting its overall financial performance. Furthermore, the company incurred an income tax expense of $0.00 indicating its tax obligations and compliance with regulatory requirements. An analysis of operational costs reveals that the company reported selling, general, and administrative expenses of $0.00 which sheds light on its operational overhead costs necessary for running day-to-day activities. The gross profit ratio is 0.00 reflecting the efficiency of the company's production and sales operations, which is crucial for long-term sustainability and growth. On the investment side, the stock is affordable at $11.15 suitable for budget-conscious investors looking for entry points in the market. Despite its affordability, the stock has a low average trading volume of 6,348.00 indicating lower market activity that may affect liquidity. With a market capitalization of $68,563,410.00 the company is classified as a small-cap player, positioning it within a specific growth segment of the market. It is a key player in the Shell Companies industry, contributing significantly to the overall market landscape and influencing trends within its sector. Furthermore, it belongs to the Financial Services sector, driving innovation and growth, which makes it an intriguing option for investors interested in emerging opportunities.
Investing in Aimei Health Technology Co., Ltd (AFJK) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Aimei Health Technology Co., Ltd stock to fluctuate between $10.24 (low) and $11.20 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-05-22, Aimei Health Technology Co., Ltd's market cap is $68,563,410, based on 6,121,733 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Aimei Health Technology Co., Ltd has a Lower Market-Cap, indicating a difference in performance.
To buy Aimei Health Technology Co., Ltd (AFJK) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AFJK. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Revenue: $0 | EPS: $0.37 | Growth: 1,847.37%.
Visit /investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $11.20 (2025-05-05) | All-time low: $10.15 (2024-01-22).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
investorplace.com
a year ago
Aimei Health Technology (NASDAQ: AFJK ) stock is surprisingly down today despite news that the blank-check company will merge with United Hydrogen Group in a special purpose acquisition company (SPAC) merger worth roughly $1.6 billion. Indeed, United Hydrogen will go public on the Nasdaq through a very fashionable SPAC merger with Aimei, with a new ticker to boot.
See all news